Insider TradingJul 22, 2026, 10:06 AM
OKYO Pharma CDO Gary Jacob Buys 3,500 Shares
AI Summary
OKYO Pharma Ltd's Chief Development Officer and Director, Gary S. Jacob, PhD, increased his stake in the company by purchasing 3,500 ordinary shares. The transaction took place on NASDAQ at $1.40 per share. This acquisition brings his total ownership to 112,420 ordinary shares, signaling increased confidence from an insider.
Key Highlights
- Gary S. Jacob, Chief Development Officer and Director, purchased 3,500 ordinary shares.
- Shares were acquired on NASDAQ at a price of $1.40 per share.
- This purchase increases his total holding to 112,420 ordinary shares.
- The transaction occurred on July 22, 2026.
Price Impact
More from OKYO